Title : YSA-conjugated mesoporous silica nanoparticles effectively target EphA2-overexpressing breast cancer cells.

Pub. Date : 2018 Apr

PMID : 29392452






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Our results suggest that EphA2-targeted MSN for doxorubicin delivery (MSN-YSA-DOX) are more effective than MSN-DOX in treating breast cancer cell lines in vitro. Doxorubicin EPH receptor A2 Homo sapiens
2 Our results suggest that EphA2-targeted MSN for doxorubicin delivery (MSN-YSA-DOX) are more effective than MSN-DOX in treating breast cancer cell lines in vitro. Doxorubicin EPH receptor A2 Homo sapiens